IDO1 is expressed in several human tumors and immune cells infiltrating the tumor mass (13) and, for this reason, IDO1 catalytic inhibitors have been used as experimental drugs in cancer immunotherapy (9, 14). The gene discussed is IDO1; the disease is cancer.